12-Year-Old Boy Hospitalized After Smoking E-cigarette at School

News by 2FIRSTS.ai

Dec.12.2023

12-Year-Old Boy Hospitalized After Smoking E-cigarette at School

12-year-old boy admitted to hospital after suffering health problems from smoking e-cigarette during break time at Möser Middle School.

According to a report from German media volksstimme on December 11th, a 12-year-old boy fell ill after smoking an e-cigarette during break time at Möser Middle School. He eventually had to be taken to the hospital.

Möser Middle School was recently exposed during a joint operation involving the police and emergency personnel after a 12-year-old boy experienced significant health issues following the use of an e-cigarette. It has been reported that on that day, a 14-year-old boy brought an e-cigarette to school, which attracted several classmates to try it during their break time.

The outcome for this 12-year-old boy is far from promising. Unable to withstand the effects of an e-cigarette, despite repeatedly vomiting, his condition did not improve. As a last resort, school authorities had no choice but to send him to the hospital.

Currently, it is known that the parents involved have received a notification from the school authorities and have personally arrived at the school. This information was obtained from the school's press conference.

References:

[1] Polizei: Zwölfjähriger Schüler in Möser nach E-Zigarette im Krankenhaus

Also Read:

[1] E-cigarette Industry: Lucrative and Popular Among Finnish Youth

[2] Major Crime Case: Drug Trafficking Targeting Students in Vietnam

[3] Florida Introduces Sniffer Dogs to Combat E-cigarette Usage in Schools

[4] Chinese E-Cigarettes: A Major Concern for US Youth

#Europe #Law enforcement #Open system e-cigarettes #Germany #E-cigarette #E-cigarettes and Tobacco

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Organigram Global Appoints Former BAT Global Head of Strategy James Yamanaka as Chief Executive Officer

Organigram Global has named James Yamanaka, previously Global Head of Strategy at British American Tobacco (BTI), as its new CEO. His appointment is expected to take effect around January 15, 2026, and he will also join the company’s board. Yamanaka brings more than 20 years of strategic and managerial experience from roles across Europe and Asia at BTI.

Nov.26

2Firsts Insights | From Limited-Edition Frenzy to Interactive Lead-Gen: The 2025 Halloween Shift in Vape Marketing

For Halloween 2025, leading vape brands such as HQD and ELFBAR are running overseas social-media engagement campaigns—covering points programs and UGC giveaways with age/region restrictions. Unlike 2024’s wave of themed devices, no brand-new Halloween limited editions have appeared on major U.S. channels this year; only RAZ has restocked last year’s version.

Oct.31 by 2FIRSTS.ai

California DOJ Outlines Next Steps for Unflavored Tobacco List; Enforcement to Target “Obviously Flavored” Products

The California DOJ issued Information Bulletin No. 2025-DLE-17 on November 10, 2025, providing an update on the state’s flavored tobacco enforcement. The Attorney General’s office is set to launch the Unflavored Tobacco List (UTL) by December 31, 2025, identifying tobacco products without characterizing flavors that may legally be sold in California. Enforcement will continue to focus on “obviously flavored” products, while unregistered products remain subject to seizure and penalties.

Nov.17 by 2FIRSTS.ai

FDA Rolls Out Online PMTA Platform, a Move That 2Firsts Analysts Say Could Pull Grey-Market Products Toward Formal Compliance

FDA’s launch of a web-based PMTA system signals faster reviews and, 2Firsts experts say, a possible inflection point for the U.S. e-cigarette market’s shift out of the grey zone.